OtherArticle
Investigation of the Influence of CYP1A2 and CYP2C19 Genetic Polymorphism on 2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide (A77 1726) Pharmacokinetics in Leflunomide-Treated Patients with Rheumatoid Arthritis
Petra Bohanec Grabar, Iztok Grabnar, Blaž Rozman, Dušan Logar, Matija Tomšič, Daša Šuput, Tina Trdan, Lucija Peterlin Mašič, Aleš Mrhar and Vita Dolžan
Drug Metabolism and Disposition October 2009, 37 (10) 2061-2068; DOI: https://doi.org/10.1124/dmd.109.027482
Petra Bohanec Grabar
Iztok Grabnar
Blaž Rozman
Dušan Logar
Matija Tomšič
Daša Šuput
Tina Trdan
Lucija Peterlin Mašič
Aleš Mrhar
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherArticle
Investigation of the Influence of CYP1A2 and CYP2C19 Genetic Polymorphism on 2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide (A77 1726) Pharmacokinetics in Leflunomide-Treated Patients with Rheumatoid Arthritis
Petra Bohanec Grabar, Iztok Grabnar, Blaž Rozman, Dušan Logar, Matija Tomšič, Daša Šuput, Tina Trdan, Lucija Peterlin Mašič, Aleš Mrhar and Vita Dolžan
Drug Metabolism and Disposition October 1, 2009, 37 (10) 2061-2068; DOI: https://doi.org/10.1124/dmd.109.027482
OtherArticle
Investigation of the Influence of CYP1A2 and CYP2C19 Genetic Polymorphism on 2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide (A77 1726) Pharmacokinetics in Leflunomide-Treated Patients with Rheumatoid Arthritis
Petra Bohanec Grabar, Iztok Grabnar, Blaž Rozman, Dušan Logar, Matija Tomšič, Daša Šuput, Tina Trdan, Lucija Peterlin Mašič, Aleš Mrhar and Vita Dolžan
Drug Metabolism and Disposition October 1, 2009, 37 (10) 2061-2068; DOI: https://doi.org/10.1124/dmd.109.027482
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement